[1]
Miles, B.J. et al. 2013. Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline. Canadian Urological Association Journal. 4, 4 (Apr. 2013), 263–7. DOI:https://doi.org/10.5489/cuaj.878.